REMI Stock Chart & Stats
$0.01
$0.00(0.00%)
At close: 4:00 PM EST
$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.01 - $0.01
Previous CloseN/A
Volume20.00
Average Volume (3M)13.21K
Market Cap
$14.00K
Enterprise Value-$13.83K
Total Cash (Recent Filing)$43.30K
Total Debt (Recent Filing)$15.48K
Price to Earnings (P/E)―
Beta-0.11
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding19,995,970
10 Day Avg. Volume10,160
30 Day Avg. Volume13,207
Financial Highlights & Ratios
PEG Ratio0.06
Price to Book (P/B)0.57
Price to Sales (P/S)1.32
P/FCF Ratio-10.01
Enterprise Value/Market Cap-0.99
Enterprise Value/Revenue-0.01
Enterprise Value/Gross Profit-0.02
Enterprise Value/Ebitda0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
REMI FAQ
What was Remedent Inc’s price range in the past 12 months?
Remedent Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.
What is Remedent Inc’s market cap?
Remedent Inc’s market cap is $14.00K.
When is Remedent Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Remedent Inc’s earnings last quarter?
Remedent Inc released its earnings results on Feb 14, 2018. The company reported $0.003 earnings per share for the quarter, beating the consensus estimate of N/A by $0.003.
Is Remedent Inc overvalued?
According to Wall Street analysts Remedent Inc’s price is currently Overvalued.
Does Remedent Inc pay dividends?
Remedent Inc does not currently pay dividends.
What is Remedent Inc’s EPS estimate?
Remedent Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Remedent Inc have?
Remedent Inc has 19,995,970 shares outstanding.
What happened to Remedent Inc’s price movement after its last earnings report?
Remedent Inc reported an EPS of $0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Remedent Inc?
Currently, no hedge funds are holding shares in REMI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Remedent Inc
Remedent, Inc., operating through its various subsidiaries, specializes in the research, development, manufacturing, and distribution of products for both oral hygiene and aesthetic dentistry. The company's core offerings include professional-grade dental veneers and teeth whitening systems, designed for use by dental practitioners as well as for over-the-counter purchase by consumers. Its innovative product portfolio features River8, a pre-fabricated veneer solution that assists dentists in achieving optimal tooth alignment with minimal patient tooth reshaping. Additionally, Remedent supplies GlamSmile veneers, which are exceptionally thin shells bonded to the front surfaces of a patient's teeth. Beyond physical products, the company offers a suite of digital tools and services aimed at enhancing dental practice operations. These include the SmileMe Mirror, an integrated marketing concept that enables quick smile consultations in about ten minutes; SmileSketch, simulation software capable of creating visual previews of potential aesthetic results; and various "Treatment Pages" designed to explain the advantages of specific dental procedures. Furthermore, Remedent provides the Condor, an advanced intra-oral 3D scanning device. The company's expertise also extends to dental implant technologies and related treatment methodologies. Remedent distributes its products to dental professionals in nearly 30 countries, spanning regions such as Asia, Europe, the Middle East, Canada, and the United States, utilizing both its internal sales team and third-party distributors. Founded in 1986, the company's corporate headquarters are located in Ghent, Belgium.
Technical Analysis
Ownership Overview
―
Insiders
―
Mutual Funds
19.76% Other Institutional Investors
80.24% Public Companies and
Individual Investors